港股異動 | 中信股份(0267.HK)升超3%領漲恆指成份股 股價創14個月新高
格隆匯5月7日丨中信股份(0267.HK)延續漲勢,再度拉昇漲超3%為最佳恆指成份股。報8.85港元創14個月新高價,總市值達2560億港元。中信股份3月底公佈2020年度業績稱,期內錄得歸屬於普通股股東淨利潤566億港元,同比增長5%。國內疫情緩解後,公司旗下業務全面復工復產,下半年淨利潤同比增長45%。績後該股持續拉昇上揚,區間漲幅超30%,不斷刷新階段新高價。高盛此前上調中信股份2021至2023年各年每股盈測介乎17%至19%,以反映業績及集團優化業務結構的努力,料今明兩年純利分別升13%及6%,至分別640億及675億港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.